Captopril treatment prevents neutrophil activation through a potential ACE-related pathway in LTB4 activation, an inflammatory signal molecule involved in many conditions, such as psoriasis and atherosclerosis [48, 124]. The gene discussed is ACE; the disease is atherosclerosis.